Literature DB >> 20818596

Mode of delivery and outcomes in very low-birth-weight infants in the vertex presentation.

Danielle E Durie1, Anthony C Sciscione, Matthew K Hoffman, Amy B Mackley, David A Paul.   

Abstract

We sought to determine the relationship between mode of delivery and neonatal outcomes in infants <1500 g in a vertex presentation. This was a retrospective cohort study of singleton, vertex-presenting infants weighing <1500 g in a level III neonatal intensive care unit between July 1993 and July 2006. Infants were divided into vaginal or cesarean delivery, and outcomes were compared with univariable and multivariable analysis. Of the 937 infants that met inclusion criteria, 402 (42.9%) underwent cesarean delivery. After controlling for potential confounding variables, there was no increased odds of death (odds ratio [OR] = 1.6: 95% confidence interval [CI] 0.8 to 3.0), severe intraventricular hemorrhage (IVH; OR = 1.2: 95% CI 0.7 to 1.2), necrotizing enterocolitis (OR = 0.82: 95% CI 0.35 to 1.9), or sepsis (OR = 0.79: 95% CI 0.44 to 13) in the vaginally delivered group compared with the cesarean group. In a post hoc analysis, this study had 80% power to detect an absolute difference in death or severe IVH of 6% between study groups, with an α of 0.05. In our population of very low-birth-weight infants, there was no association between mode of delivery and neonatal outcomes. © Thieme Medical Publishers.

Entities:  

Mesh:

Year:  2010        PMID: 20818596     DOI: 10.1055/s-0030-1266156

Source DB:  PubMed          Journal:  Am J Perinatol        ISSN: 0735-1631            Impact factor:   1.862


  6 in total

1.  Prevention and Therapy of Preterm Birth. Guideline of the DGGG, OEGGG and SGGG (S2k Level, AWMF Registry Number 015/025, February 2019) - Part 2 with Recommendations on the Tertiary Prevention of Preterm Birth and the Management of Preterm Premature Rupture of Membranes.

Authors:  Richard Berger; Harald Abele; Franz Bahlmann; Ivonne Bedei; Klaus Doubek; Ursula Felderhoff-Müser; Herbert Fluhr; Yves Garnier; Susanne Grylka-Baeschlin; Hanns Helmer; Egbert Herting; Markus Hoopmann; Irene Hösli; Udo Hoyme; Alexandra Jendreizeck; Harald Krentel; Ruben Kuon; Wolf Lütje; Silke Mader; Holger Maul; Werner Mendling; Barbara Mitschdörfer; Tatjana Nicin; Monika Nothacker; Dirk Olbertz; Werner Rath; Claudia Roll; Dietmar Schlembach; Ekkehard Schleußner; Florian Schütz; Vanadin Seifert-Klauss; Susanne Steppat; Daniel Surbek
Journal:  Geburtshilfe Frauenheilkd       Date:  2019-08-12       Impact factor: 2.915

2.  Neonatal mortality by attempted route of delivery in early preterm birth.

Authors:  Uma M Reddy; Jun Zhang; Liping Sun; Zhen Chen; Tonse N K Raju; S Katherine Laughon
Journal:  Am J Obstet Gynecol       Date:  2012-06-19       Impact factor: 8.661

3.  Maternal morbidity by attempted route of delivery in periviable birth.

Authors:  Tetsuya Kawakita; Tavor Sondheimer; Angie Jelin; Uma M Reddy; Helain J Landy; Chun-Chih Huang; Patrick S Ramsey; Michelle A Kominiarek; Katherine L Grantz
Journal:  J Matern Fetal Neonatal Med       Date:  2019-06-26

4.  Trends in incidence of neonatal sepsis and antibiotic susceptibility of causative agents in two neonatal intensive care units in tehran, I.R iran.

Authors:  Shahla Afsharpaiman; Mohammad Torkaman; Amin Saburi; Amir Farzaampur; Susan Amirsalari; Zohreh Kavehmanesh
Journal:  J Clin Neonatol       Date:  2012-07

5.  Survival rate of extremely low birth weight infants and its risk factors: case-control study in Japan.

Authors:  Masaki Ogawa; Yoshio Matsuda; Eriko Kanda; Jun Konno; Minoru Mitani; Yasuo Makino; Hideo Matsui
Journal:  ISRN Obstet Gynecol       Date:  2013-11-25

6.  Mode of delivery and pregnancy outcomes in preterm birth: a secondary analysis of the WHO Global and Multi-country Surveys.

Authors:  Bao Yen Luong Thanh; Pisake Lumbiganon; Porjai Pattanittum; Malinee Laopaiboon; Joshua P Vogel; Olufemi T Oladapo; Cynthia Pileggi-Castro; Rintaro Mori; Kapila Jayaratne; Zahida Qureshi; Joã Souza
Journal:  Sci Rep       Date:  2019-10-29       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.